Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Sale |
2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
Commodore Capital LP | 700,000 2.300% |
-185,741 (-20.97%) |
Filing History |
| 2024-02-13 5:35 pm Purchase |
2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
JANUS HENDERSON GROUP PLC JHG |
2,523,897 8.300% |
1,064,197 (+72.91%) |
Filing History |
| 2024-02-07 08:01 am Purchase |
2023-12-31 | 13G | Soleno Therapeutics, Inc. SLNO |
ADAGE CAPITAL PARTNERS GP LLC | 1,826,814 5.990% |
499,814 (+37.66%) |
Filing History |
| 2023-10-23 4:20 pm Unchanged |
2023-10-20 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 3,074,542 10.100% |
0 (Unchanged) |
Filing History |
| 2023-10-16 4:30 pm Purchase |
2023-10-12 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
2,893,615 9.990% |
1,326,368 (+84.63%) |
Filing History |
| 2023-10-12 4:30 pm Purchase |
2023-10-02 | 13G | Soleno Therapeutics, Inc. SLNO |
ADAGE CAPITAL PARTNERS GP LLC | 1,327,000 8.690% |
1,327,000 (New Position) |
Filing History |
| 2023-10-12 4:05 pm Purchase |
2023-10-02 | 13G | Soleno Therapeutics, Inc. SLNO |
Commodore Capital LP | 885,741 6.000% |
885,741 (New Position) |
Filing History |
| 2023-10-11 4:30 pm Unchanged |
2023-10-02 | 13D | Soleno Therapeutics, Inc. SLNO |
Vivo Opportunity Fund Holdings, L.P. | 8,418,093 30.500% |
0 (Unchanged) |
Filing History |
| 2023-10-10 4:30 pm Purchase |
2023-09-28 | 13G | Soleno Therapeutics, Inc. SLNO |
Fairmount Funds Management LLC | 950,000 6.200% |
950,000 (New Position) |
Filing History |
| 2023-10-06 11:45 am Purchase |
2023-09-26 | 13G | Soleno Therapeutics, Inc. SLNO |
JANUS HENDERSON GROUP PLC JHG |
1,459,700 10.100% |
1,459,700 (New Position) |
Filing History |
| 2023-10-05 5:09 pm Purchase |
2023-09-26 | 13G | Soleno Therapeutics, Inc. SLNO |
RA Capital Management, L.P. | 1,233,300 4.600% |
1,233,300 (New Position) |
Filing History |
| 2023-10-03 4:05 pm Purchase |
2023-09-28 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
1,567,247 9.990% |
339,930 (+27.70%) |
Filing History |
| 2023-09-28 9:51 pm Purchase |
2023-09-26 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 3,074,542 23.700% |
866,789 (+39.26%) |
Filing History |
| 2023-08-30 4:05 pm Purchase |
2023-06-06 | 13G | Soleno Therapeutics, Inc. SLNO |
HIRSCHMAN ORIN | 498,610 4.900% |
76,121 (+18.02%) |
Filing History |
| 2023-08-18 4:15 pm Purchase |
2023-08-08 | 13D | Soleno Therapeutics, Inc. SLNO |
Carlyle Group Inc. CG |
1,227,317 12.300% |
1,227,317 (New Position) |
Filing History |
| 2023-08-15 4:15 pm Unchanged |
2023-08-15 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 2,207,753 22.100% |
0 (Unchanged) |
Filing History |
| 2023-06-06 4:17 pm Purchase |
2023-06-02 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 2,207,753 27.000% |
178,298 (+8.79%) |
Filing History |
| 2023-06-01 5:00 pm Purchase |
2023-05-25 | 13D | Soleno Therapeutics, Inc. SLNO |
Vivo Opportunity Fund Holdings, L.P. | 8,418,093 50.800% |
8,418,093 (New Position) |
Filing History |
| 2023-05-30 4:15 pm Purchase |
2023-05-26 | 13D | Soleno Therapeutics, Inc. SLNO |
PERCEPTIVE ADVISORS LLC | 2,029,455 24.800% |
85,000 (+4.37%) |
Filing History |
| 2023-05-26 1:14 pm Purchase |
2022-11-04 | 13D | Soleno Therapeutics, Inc. SLNO |
SCHULER JACK W | 421,976 4.990% |
421,976 (New Position) |
Filing History |